摘要
目的针对于出现慢阻肺的病人选择多索茶碱联合噻托溴铵粉展开治疗,对其临床研究进行分析。方法本研究所选择的研究对象为2017年5月至2018年2月我院所收治的慢阻肺病人30例,对其中10例采取的治疗方法为单一的多索茶碱治疗,为对照组,针对另外20例病人在选用多索茶碱进行治疗的基础上实施噻托溴铵粉联合治疗,为联合组,对两组病人的治疗有效情况展开观察。结果数据表明,采取联合治疗的联合组治疗有效情况要优于对照组,运用统计学方法对其进行分析,存在明显差别P<0.05。结论针对于出现慢阻肺的病人选择治疗方案时可以选取多索茶碱联合噻托溴铵粉的方法,具有显著的疗效,可以进行临床推广使用。
Objective To have COPD patients choose doxofylline combined with tiotropium bromide powder of treatment, the clinical research and analysis. Methods 30 cases of patients with COPD subjects in this study are selected from May 2017 to February 2018 treated in our hospital, of which 10 cases take the therapy method for single doxofylline treatment, as the control group, the other 20 patients in the selection of doxofylline treatment on the basis of the implementation of tiotropium bromide powder combination therapy, combination group, effective treatment of the patients in the two groups of observation. Results The data showed that the combined treatment group had better effect than the control group, and there was a significant difference between them by statistical methods, P〈0.05. Conclusion The method for the emergence of COPD patients＇ treatment options can be selected doxofyline combined with tiotropium bromide powder, has significant curative effect, for clinical use.
作者
何通
HE Tong(The Second Hospital of Zunhua,Tangshan,Hebei,06420)
出处
《智慧健康》
2018年第8期99-100,共2页
Smart Healthcare
关键词
多索茶碱
噻托溴铵粉
慢阻肺
Doxofylline
Tiotropium bromide powder
Chronic obstructive pulmonary disease
